Table 9. 18 circRNAs* for primary screening.
| CircRNA ID | CircRNA type | Chrom |
| Upregulated circRNAs | ||
| hsa_circ_ 0002113 | exonic | Chr21 |
| hsa_circ_ 0001667 | exonic | Chr7 |
| hsa_circ_ 0006528 | exonic | Chr5 |
| hsa_circ_ 0002874 | exonic | Chr9 |
| hsa_circ_ 0002168 | exonic | Chr20 |
| hsa_circ_ 0086241 | exonic | Chr9 |
| hsa_circ_ 0007769 | exonic | Chr6 |
| hsa_circ_ 0092276 | intronic | Chr3 |
| hsa_circ_ 0044556 | exonic | Chr17 |
| hsa_circ_ 0003183 | exonic | Chr8 |
| hsa_circ_ 0085567 | exonic | Chr8 |
| hsa_circ_ 0085495 | exonic | Chr8 |
| Downregulated circRNAs | ||
| hsa_circ_ 0008131 | exonic | ChrX |
| hsa_circ_ 0003838 | exonic | Chr15 |
| hsa_circ_ 0007551 | exonic | Chr5 |
| hsa_circ_ 0005004 | exonic | Chr7 |
| hsa_circ_ 0006903 | exonic | Chr12 |
| hsa_circ_ 0018293 | exonic | Chr10 |
* According to Screening circular RNA related to chemotherapeutic resistance in breast cancer [14].